KAISER PETER (Chief Development Officer) sold 1.1% of their position (3.04K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $32.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/26/2026ACC: 0001104659-26-101674
Officer· Chief Development Officer
Since Feb 2026
-3.04K
Net shares
Net seller
$32.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.04K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.04K
Price / share
$10.77
Trade value
$32.69K
% of position
1.1%
8/24/2026
267.41K→264.38K
Total
Net shares
−3.04K
Net value
-$32.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/24/2026 | S · Sale | −3.04K | $10.77 | $32.69K | 1.1% | 267.41K | 264.38K |
| Total | −3.04K | -$32.69K | ||||||
Derivative Transactions0
No derivative transactions reported